Opinion: Trump’s $150-per-month GLP-1 plan won’t reach people like me​Opinion: Trump’s $150-per-month GLP-1 plan won’t reach people like me 

On Oct. 16, President Trump promised to slash the price of brand-name GLP-1 drugs like Ozempic and Wegovy to $150 a month. Even after a top health official suggested price negotiations between drugmakers and the administration were ongoing, the announcement sent Novo Nordisk and Eli Lilly stocks tumbling. For patients who’ve been priced out, that Read More

Doctors using AI mammogram readings to predict breast cancer risk​Doctors using AI mammogram readings to predict breast cancer risk 

Breast cancer is the second-leading cause of cancer deaths in women. About one in eight women will be diagnosed with the disease in their lifetimes. To combat that, some doctors are using AI as a tool to help them not only detect breast cancer, but also predict a woman’s risk factors. Dr. Connie Lehman, founder of Clarity, joins CBS News to discuss the first FDA-authorized AI platform used to predict a woman’s 5-year risk of developing breast cancer.

GLP-1s and Heart Attacks, Strokes; Measles Outbreak Spreads; Using AI to Find PCPs​GLP-1s and Heart Attacks, Strokes; Measles Outbreak Spreads; Using AI to Find PCPs 

(MedPage Today) — Note that some links may require registration or subscription. Semaglutide (Wegovy) cut the risk for major heart events in people with obesity and cardiovascular disease regardless of how much weight they lost. (The Lancet… ​ (MedPage Today) — Note that some links may require registration or subscription. Semaglutide (Wegovy) cut the risk Read More